In Short: Dr Reddy’s Laboratories launched Doxycycline capsules 40 mg in the US market, which is a generic version of ORACEA. The company specified that these capsules should not be used for treating bacterial infections or preventing infections. USFDA has approved this formulation, but it is not intended for antibacterial purposes. Exciting News from Dr. […]This news is sourced from India Telecom News.

More...